Original Article

Synthesis, anti-angiogenic activity and prediction toxicity of (E)-3-(3-methoxyphenyl) propenoic acid

Juni Ekowati, Kholis A. Nofianti, Maya N. Yunita, Iwan S. Hamid, Fitria Dwiningrum, Darwin R. Ramadhan, Ghinalya C. Ananda
Journal of Public Health in Africa | Vol 14, S 1 : 4th Joint Conference of UNAIR-USM, International Conference of Pharmacy and Health Sciences ICPHS| a142 | DOI: https://doi.org/10.4081/jphia.2023.2534 | © 2024 Juni Ekowati, Kholis A. Nofianti, Maya N. Yunita, Iwan S. Hamid, Fitria Dwiningrum, Darwin R. Ramadhan, Ghinalya C. Ananda | This work is licensed under CC Attribution 4.0
Submitted: 03 April 2024 | Published: 30 March 2023

About the author(s)

Juni Ekowati, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
Kholis A. Nofianti, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
Maya N. Yunita, Department of Pathology Veterinary, Faculty of Veterinary Medicine, PSDKU Banyuwangi, Indonesia
Iwan S. Hamid, Department of Basic Veterinary, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia
Fitria Dwiningrum, Bachelor Program Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
Darwin R. Ramadhan, Bachelor Program Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
Ghinalya C. Ananda, Dentist Professional Program, Faculty of Dentistry Medicine, Universitas Airlangga, Surabaya, Indonesia

Full Text:

PDF (724KB)

Abstract

Background: Anti-angiogenic medications, one of cancer chemo preventive mechanism were permitted for different cancers. Nevertheless, major primary and secondary resistance obstruct efficacy in several tumor types. Moreover, the improvement of safe and effective NSAIDs for angiogenesis inhibition is complicated, because of their serious toxicity. So, we require improving clinically appropriate strategies to boost efficacy of anti-angiogenic drugs with low risk of toxicity. Objectives: The present study aimed to synthesize the (E)-3- (3-methoxyphenyl)propenoic acid (3MPCA), to determine the anti-angiogenic activity and predict its toxicity. Methods: 3MPCA was obtained by Knoevenagel reaction using microwave irradiation at 400 Watt. The anti-angiogenesis experimental was performed using chorioallantois membrane of embryonated chicken eggs induced by b-FGF. The potency of 3MPCA was verified at dosage 30 and 60 ng and compared with celecoxib 60 ng. Toxicity prediction of 3MPCA was performed by ProTox II online program. Results: The results showed that 3MPCA was achieved in good yield (89%). Anti angogenic activity was showed by endothelial cells growth in neovascular capillaries of new blood vessel of chorioallantois membrane of embryonated chicken eggs. The endothelial cells growth decreased until 41.7-83%. The prediction LD50 was 1772mg/kg. Conclusion: (E)-3-(3-methoxyphenyl)propenoic acid can be obtained through Knovenagel reaction using microwave irradiation and it has potential as anti-angiogenesis inhibitor with low toxicity.

Keywords

Anti-angiogenesis; good health and well-being; m-methoxy cinnamic acid; (E)-3-(3-methoxyphenyl) propenoic acid

Metrics

Total abstract views: 209
Total article views: 32


Crossref Citations

No related citations found.